The US Food and Drug Administration (FDA) has approved once-daily nevirapine extended-release tablets (Viramune XR; Boehringer Ingelheim Pharmaceuticals Inc) for use in combination with other antiretroviral agents for the treatment of HIV-1 in adults.
Read the Full Article